BenjaminMouMDFRCPC
Radiation Oncology • Rochester, MNCentral Nervous System Cancer, Gastrointestinal Cancer, Thoracic Cancer
Radiation Oncologist, Clinical Associate Professor
Dr. Mou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 1st St Sw
Rochester, MN 55905- Is this information wrong?
Education & Training
Mayo Clinic2013 - 2014
Michael G. DeGroote School of MedicineClass of 2008
University of Western OntarioBSc, Mathematics, With Distinction, 2002 - 2005
Certifications & Licensure
MN State Medical License 2013 - 2016- American Board of Radiology Radiation Oncology
- Royal College of Physicians and Surgeons of CanadaRadiation Oncology
Awards, Honors, & Recognition
- Top 40 Under 40 Kelowna Chamber of Commerce, 2022
- Roentgen Resident/Fellow Research Award RSNA, 2013
Clinical Trials
- SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone Metastases Start of enrollment: 2019 Dec 02
- Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer Start of enrollment: 2019 Nov 01
- SCION: SABR and Checkpoint Inhibition Of NSCLC Start of enrollment: 2023 Aug 11
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsUpfront Versus Delayed Systemic Therapy in Patients With Oligometastatic Cancer Treated With SABR in the Phase 2 SABR-5 Trial.Mou, B., Sarah Baker, Linden Lechner, Mitchell Liu, Jee Suk Chang, Ella Mae Cruz-Lim, Ben Mou, Will Jiang, Alanah Bergman, Devin Schellenberg, Abraham Alexander, Tanya...> ;International Journal of Radiation Oncology, Biology, Physics. 2024 Apr 1
- Prospective Longitudinal Assessment of Quality of Life After Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-based SABR-5 Phase II T...Mou, B., Mou, B., Mou, B., E M Cruz-Lim, B Mou, S Baker, G Arbour, K Stefanyk, W Jiang, M Liu, A Bergman, D Schellenberg, A Alexander, T Berrang, A Bang, N Chng, Q Mat...> ;Clinical Oncology. 2024 Mar 1
- Predictors of Quality of Life Decline in Patients with Oligometastases treated with Stereotactic Ablative Radiotherapy: Analysis of the Population-Based SABR-5 Phase I...Mou, B., E M Cruz-Lim, B Mou, W Jiang, M Liu, A Bergman, D Schellenberg, A Alexander, T Berrang, A Bang, N Chng, Q Matthews, H Carolan, F Hsu, S Miller, S Atrchian, E ...> ;Clinical Oncology. 2024 Mar 1
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
